Jim Hoffman: Affinity-Based Blood Purification as a Potential Alternative to Plasma Exchange
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn:
“A business model for improved therapeutic extracorporeal blood purification methods to follow that are capable of depleting toxic levels of extracellular chromatin from the blood.
These newer affinity-based methods , which effectively deplete extracellular chromatin and allow patients to keep their own blood with greatly reduced toxic levels of extracellular chromatin, should be evaluated as a replacement for more expensive and likely less effective Therapeutic Plasma Exchange (TPE).
This could greatly increase badly needed affordable access to treatment and potentially prevent and treat chronic illness disease progression more efficaciously than TPE.
A small sampling of the research implicating elevated extracellular chromatin contributing to multi-organ injury and disease progression:”
Find more posts featuring Jim Hoffman on Hemostasis Today.
-
Feb 9, 2026, 17:17RishiRaj Sinha: Strengthening Donor Connections – A Forward Path for 2026, Insights From the Indian Subcontinent
-
Feb 9, 2026, 17:12Anna Randi: Latest VWD and Hemophilia A Research at EAHAD 2026
-
Feb 9, 2026, 17:08Gerard J Myers: Pulmonary Vascular Air Embolism in Mechanically Ventilated Newborn Infants
-
Feb 9, 2026, 16:50Save the Date for WSC 2026 in Seoul – World Stroke Organization
-
Feb 9, 2026, 16:44Rose Almashayekh: You Can’t Always See Health – Lessons from Marfan Syndrome
-
Feb 9, 2026, 15:16Ed Shovelin: Pplus Medical Limited Will Be Giving Demos of the Platelet DSD at ICTHIC 2026
-
Feb 9, 2026, 15:12Ana Boban Elected as EAHAD President for 2026–2028
-
Feb 9, 2026, 14:54EAHAD and EHC Webinar on Platelet Disorders Ahead of Rare Disease Day 2026
-
Feb 9, 2026, 14:49Armando Ramirez։ Key Takeaways from NLA’s Updated Clinical Guidance on Familial Hypercholesterolemia